Tytuł pozycji:
Increasing hydroxyurea use in children with sickle cell disease at Kamuzu Central Hospital, Malawi.
-
Tytuł:
-
Increasing hydroxyurea use in children with sickle cell disease at Kamuzu Central Hospital, Malawi.
-
Autorzy:
-
Mvalo T; University of North Carolina Project-Malawi, Lilongwe, Malawi.; Department of Pediatrics.
Topazian H; University of North Carolina Project-Malawi, Lilongwe, Malawi.; Department of Epidemiology, and.
Kamthunzi P; University of North Carolina Project-Malawi, Lilongwe, Malawi.; Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC.
Chen J; University of North Carolina Project-Malawi, Lilongwe, Malawi.; Department of Epidemiology, and.
Kambalame I; University of North Carolina Project-Malawi, Lilongwe, Malawi.
Mafunga P; University of North Carolina Project-Malawi, Lilongwe, Malawi.
Mumba N; University of North Carolina Project-Malawi, Lilongwe, Malawi.
Chiume-Chiphaliwali M; Department of Pediatrics, and.
Paseli K; Ministry of Health, Kamuzu Central Hospital, Lilongwe, Malawi; and.
Key N; Division of Hematology, and.
Gopal S; University of North Carolina Project-Malawi, Lilongwe, Malawi.; Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC.
Hoffman I; University of North Carolina Project-Malawi, Lilongwe, Malawi.; Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC.
Ataga K; Division of Hematology, and.
Westmoreland K; University of North Carolina Project-Malawi, Lilongwe, Malawi.; Division of Pediatric Hematology-Oncology, University of North Carolina, Chapel Hill, NC.
-
Źródło:
-
Blood advances [Blood Adv] 2018 Nov 30; Vol. 2 (Suppl 1), pp. 30-32.
-
Typ publikacji:
-
Journal Article; Observational Study; Research Support, N.I.H., Extramural
-
Język:
-
English
-
Imprint Name(s):
-
Original Publication: Washington, DC : American Society of Hematology, [2016]-
-
MeSH Terms:
-
Anemia, Sickle Cell/*drug therapy
Antisickling Agents/*therapeutic use
Hydroxyurea/*therapeutic use
Adolescent ; Anemia, Sickle Cell/blood ; Anemia, Sickle Cell/epidemiology ; Anemia, Sickle Cell/urine ; Antisickling Agents/administration & dosage ; Antisickling Agents/adverse effects ; Child ; Child, Preschool ; Female ; Hospitals, Teaching ; Humans ; Hydroxyurea/administration & dosage ; Hydroxyurea/adverse effects ; Infant ; Malawi/epidemiology ; Male ; Prospective Studies
-
Grant Information:
-
D43 TW010060 United States TW FIC NIH HHS; U01 HL117659 United States HL NHLBI NIH HHS
-
Substance Nomenclature:
-
0 (Antisickling Agents)
X6Q56QN5QC (Hydroxyurea)
-
Entry Date(s):
-
Date Created: 20181204 Date Completed: 20190911 Latest Revision: 20201016
-
Update Code:
-
20240105
-
PubMed Central ID:
-
PMC6438283
-
DOI:
-
10.1182/bloodadvances.2018GS110347
-
PMID:
-
30504195
-
